|
|
|
22.08.25 - 18:39
|
Saudi Arabia Diabetes Drug Market Trends and Company Analysis Report 2025-2033 Featuring Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, and Novartis - ResearchAndMarkets.com (Business Wire)
|
|
|
DUBLIN--(BUSINESS WIRE)--The "Saudi Arabia Diabetes Drug Market Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering.
The Saudi Arabia Diabetes Drug Market is anticipated to grow to US$ 1.33 billion by 2033, from US$ 773.6 million in 2024, growing at a CAGR of 6.22% from 2025 to 2033
This growth is due to an increase in the prevalence of diabetes, enhanced awareness, government healthcare expenditure, and acceptance of new therapeutic agents like SGLT2 inhibitors, GLP-1 receptor agonists, and biosimilar insulins.
Diabetes medication in Saudi Arabia is experiencing growing popularity because of the prevalence of diabetes, which is largely caused by sedentary lifestyles, eating habits, and obesity. Strategic government efforts, such as Vision 2030, focus on enhanced access to healthcare and chronic disease management. The increasing number of diabetics, heightened awareness, and upgraded diagnostic facilities are driving demand for traditional as well as advanced treatmen...
|
|
|
22.08.25 - 08:00
|
Valneva-Aktie on fire: Das ist jetzt noch drin (Sharedeals)
|
|
|
Völlig außer Rand und Band präsentiert sich derzeit die Aktie des französischen Impfstoffherstellers Valneva. Sie hat ihren Wert in den letzten sechs Wochen in etwa verdoppelt und ist zuletzt auf ein 18-Monats-Hoch bei 5,415 € gestiegen. Was steckt hinter dieser Kursrallye? Und hat die Aktie weiteres Aufwärtspotenzial? Positiver Newsflow treibt an Eine Reihe von positiven […]
The post Valneva-Aktie on fire: Das ist jetzt noch drin first appeared on sharedeals.de....
|
|
|
21.08.25 - 13:06
|
Leaders Come Together to Advance the Industry at Veeva Summit (PR Newswire)
|
|
|
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, including deep industry-specific Veeva AI in Vault Platform and Veeva applications PLEASANTON,......
|
|
|
21.08.25 - 13:03
|
Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book (GlobeNewswire EN)
|
|
|
SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that U.S. Patent No. 12,377,064 covering the use of GIMOTI® (metoclopramide) nasal spray in patients with moderate to severe symptoms of gastroparesis, has been listed in the U.S. Food and Drug Administration's (FDA) Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the “Orange Book”....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.08.25 - 09:33
|
Virbac:: Paul Martingell′s compensation terms (GlobeNewswire EN)
|
|
|
The board of directors, acting upon the recommendation of the appointments and compensation committee, has approved the compensation terms for Paul Martingell for the duration of his mandate, as detailed below. In accordance with applicable regulations, Paul Martingell's compensation elements will be submitted for the approval of the shareholders ("ex ante" and "ex post" votes)....
|
|
|
|
|
18.08.25 - 07:03
|
Valneva′s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and Older (GlobeNewswire EN)
|
|
|
Saint Herblain (France), August 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has granted marketing authorization for its single-dose vaccine, IXCHIQ®, for the prevention of disease caused by the chikungunya virus in individuals aged 12 years and older. This announcement adds to the adult marketing authorization already received in Canada1 and complements the adolescent label extension received in Europe in April 20252....
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
